HDAC10 inhibition represses melanoma cell growth and BRAF inhibitor resistance via upregulating SPARC expression is a research paper published in NAR Cancer (2024). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01CA240529
National Institutes of Health
Grant: R01AI153110
National Institutes of Health
Grant: R01CA270149
National Institutes of Health
Grant: 5R01CA240529-05
Regulation of anti-tumor immunity by HDAC11
National Institutes of Health
Grant: 5R01AI153110-03
Design and development of HDAC11-specific chemical inhibitors for disease treatments
National Institutes of Health
Grant: 1R01CA270149-01A1
Targeting lysine acetyltransferase MOF/KAT8 in lung cancer
FWCI
2.43
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals